| Literature DB >> 34368207 |
Xin-Xin Zhao1,2, Fang-Jun Lin3, Hang Li1, Hua-Bin Li4, Ding-Tao Wu5, Fang Geng5, Wei Ma1,2, Yu Wang1,2, Bao-He Miao1,2, Ren-You Gan1,2,5.
Abstract
Onion (Allium cepa L.) is a common vegetable, widely consumed all over the world. Onion contains diverse phytochemicals, including organosulfur compounds, phenolic compounds, polysaccharides, and saponins. The phenolic and sulfur-containing compounds, including onionin A, cysteine sulfoxides, quercetin, and quercetin glucosides, are the major bioactive constituents of onion. Accumulated studies have revealed that onion and its bioactive compounds possess various health functions, such as antioxidant, antimicrobial, anti-inflammatory, anti-obesity, anti-diabetic, anticancer, cardiovascular protective, neuroprotective, hepatorenal protective, respiratory protective, digestive system protective, reproductive protective, and immunomodulatory properties. Herein, the main bioactive compounds in onion are summarized, followed by intensively discussing its major health functions as well as relevant molecular mechanisms. Moreover, the potential safety concerns about onion contamination and the ways to mitigate these issues are also discussed. We hope that this paper can attract broader attention to onion and its bioactive compounds, which are promising ingredients in the development of functional foods and nutraceuticals for preventing and managing certain chronic diseases.Entities:
Keywords: anti-diabetic; anti-obesity; anticancer; antioxidant; phytochemicals; safety
Year: 2021 PMID: 34368207 PMCID: PMC8339303 DOI: 10.3389/fnut.2021.669805
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Bioactive compounds and health functions of onion.
Figure 2The chemical structures of the main organosulfur and phenolic compounds in onion.
The health functions and potential mechanisms of onion.
| Onion methanol extract | Rat dopaminergic cell line N27-A | 500 μg/mL | Upregulating antioxidant enzyme (HO-1, NQO1, and catalase) expressions | ( | |
| Onion powder | Rats | 10% onion powder in diets | Enhancing the activity of CAT, SOD and GPx enzymes in erythrocytes and liver | ( | |
| Onion extract | Ovalbumin-sensitized rats | 35, 70, and 140 mg/kg/d for 21 days | Enhancing the levels of SOD, CAT, and thiol | ( | |
| Onion | Potassium bromate-induced oxidative damage in rats | 10, 20, and 30% in diets | Protecting against oxidative damage; reducing MDA levels; restoring the architecture of liver and kidney cells | ( | |
| Phenolic-rich onion extract | Broiler chicks | 1, 2, and 3 g/kg diet | Increasing CAT, SOD activity, and GSH level | ( | |
| Pawpaw-onion powder | African catfish | 2.5, 5, and 10 g/kg diet | Increasing antioxidant enzyme activity | ( | |
| Onion juice | Clinical trial | Healthy subjects | 100 mL for 8 weeks | Reducing total free radicals and superoxide anions levels; elevating the glutathione content and total antioxidant capacity | ( |
| Onion liquid and lyophilized extracts | Showing high antibacterial efficiency against Gram-positive bacteria, such as | ( | |||
| Lemongrass and onion essential oils | Leafy vegetables treated with the essential oils combination showed higher antibacterial protection and odor acceptability | ( | |||
| Red onion polysaccharide fractions | Showing stronger antibacterial effect against | ( | |||
| Graphene using extract of onion | Showing great antibacterial activity | ( | |||
| Bulb extracts from onion and onion varieties | Against three Gram-positive species ( | ( | |||
| Onion husks non-polar fraction; 7-Keto-(5-6-dihydro)-β-Sitosterol | Inhibiting Quorum sensing effects; inhibiting swimming motilities | ( | |||
| Silver nanoparticles using extracts of neem, onion and tomato | Against Gram-positive bacteria | ( | |||
| Red onion skin extract | Showing great antibacterial activity | ( | |||
| Onion essential oil | Showing fungicidal or inhibitory effects on the growth of fungal species from food | ( | |||
| Onion endophytic bacterium | Showing effective antifungal effect against rice blast pathogen | ( | |||
| Red onion ethanol extract | Preventing tinea pedis caused by fungal infection | ( | |||
| Onion methanol extract | Lipopolysaccharide-induced BV-2 microglial cells | 50, 250, and 500 μg/mL | Preventing LPS-stimulated increases of proinflammatory cytokines, TNF-α, IL-6, and IL-1β; decreasing iNOS and COX-2 levels; reducing the release of NO | ( | |
| Red onion skin extract | LPS-treated RAW 264.7 cells | Inhibiting IL-6 and IL-1; decreasing the release of NO | ( | ||
| Onion-derived nanoparticles | LPS-treated RAW 264 cells | Inhibiting NO production | ( | ||
| Onion bulb extract | Isolated bone-marrow derived neutrophils | 0.01, 0.1, 1, 10, and 100 μg/ml | Reversing and preventing colitis in mice | ( | |
| Dextran sulfate sodium-induced colitis in mice | 100 and 200 mg/kg | ||||
| Onion extract | Rats | 0.175, 0.35, and 0.7 mg/mL in drinking water | Decreasing in total WBC and PLA2 level; decreasing neutrophil and eosinophil counts; increasing in lymphocytes count | ( | |
| Onion bulb extract | Dextran sulfate sodium-induced colitis in mice | 30, 60, 100, and 200 mg/kg | Modulating the expression and the activity of important pro-inflammatory molecules and signaling pathways involved in the inflammatory response | ( | |
| Onion bulb extract | Mice | 10, 30, 60, and 100 mg/kg | Alleviating house dust mite-induced perivascular and peribronchial inflammation through EGFR, ERK1/2, and AKT pathway | ( | |
| Onion aqueous extract | Carrageenan-induced paw edema in rats | 0.1, 0.5, and 1.5 mg/kg I.P injection | Reducing rat paw edema dose dependently | ( | |
| Onion peel extracts; quercetin and isoquercetin | 3T3-L1 cells | Extract 50, 100, and 150 μg/ml; quercetin and isoquercetin 25, 50, and 100 μM | Remodeling white adipocytes to brown-like adipocytes | ( | |
| HFD-fed mice | 0.5% in diets for 8 weeks | ||||
| Onion peel extract | 3T3-L1 cells | 25, 50, 100, 150, 200, 300, 400, and 500 μg/mL | Inhibiting lipid accumulation | ( | |
| HFD-fed mice | 36, 90, and 144 mg/kg for 8 weeks | Reducing body weight; lowering fat coefficient and improving serum lipid levels | |||
| Quercetin; red onion extract | HFD-fed mice | Diets with 17 mg/kg of quercetin equivalents for 9 weeks | Preventing hypermethylation in the Pgc-1α promoter | ( | |
| Onion oil | HFD-fed rats | 46.3 and 92.6 mg/kg/d for 60 days | Reducing body weight gain and tending to decrease adipose tissue weight | ( | |
| Quercetin-rich onion peel extract | Clinical trial | 72 subjects with BMI > 23 kg/m2 | 170 mg capsule contains 50 mg quercetin, 2 capsules/d for 12 weeks | Reducing weight and percentage of body fat; decreasing blood glucose and leptin levels | ( |
| Quercetin-rich onion powder | Clinical trial | 70 healthy Japanese subjects | 9 g/d for 12 weeks | Lowering alanine aminotransferase; reducing visceral fat area in lower high-density lipoprotein cholesterol subjects | ( |
| Steamed onion | Clinical trial | 70 overweight subjects | 300 mg capsule contains 37.5% steamed onion; 3 capsules/d for 12 weeks | Reducing percentage of body fat and fat mass with no significant effects on lean body mass | ( |
| Onion peel extract | Clinical trial | 61 overweight and obese subjects | Capsule contains 50 mg quercetin, 119.2 mg total polyphenol, and 65.0 mg total flavonoid; 2 capsules/d for 12 weeks | Regulating erythrocyte n-6/n-3 ratio and preventing fat accumulation in various body regions | ( |
| Onion seed extract | Streptozotocin-induced male rats | 200 and 400 mg/kg/d for 28 days | Protecting against adverse effects of diabetes on reproductive system | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Ameliorating hyperglycemia and its associated metabolic disorders | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Reducing oxidative stress | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Alleviating cardiac damage | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Attenuating diabetic nephropathy | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Ameliorating eye lens abnormalities | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Countering the deformity and fragility of erythrocytes | ( | |
| Red onion scales extract | Streptozotocin-induced diabetes in rats | 150 and 300 mg/kg/d for 4 weeks | Improving fasting blood glucose and advanced glycation end products levels; elevating serum insulin level; down-regulating inflammatory mRNA expression | ( | |
| Heat-processed onion extract | Male rats | 500 mg/kg | Showing anti-diabetic effect by suppressing carbohydrate absorption | ( | |
| Fenugreek seeds and onion | Streptozotocin-induced diabetes in rats | 10% fenugreek seeds or 3% onion or their combination in diet for 6 weeks | Attenuating diabetic nephropathy | ( | |
| Onion peel extract/onion powder | Alloxan-induced diabetes in rats | 1 and 3% onion peel extract, 5 and 7% onion powder in bread | Reducing blood glucose and MDA levels; improving antioxidant enzyme activities | ( | |
| Raw red onion | clinical trial | 53 overweight or obese non-diabetic patients with polycystic ovary syndrome | 2 × 40–50 g/d for overweight and 2 × 50–60 g/d for obese patients or 2 × 10–15 g/d for 8 weeks | Improving insulin resistance markers; increasing the chance of menses occurrence | ( |
| Onion methanolic extract | MDA-MB-231 cells; A1235 cells | 100 μg/mL in a complete medium | Inhibiting tumor cells proliferation | ( | |
| Onion varieties extract | Caco-2 cells | 1:10 dilution (10 μL of extract with 90 μL of growth media) | Inhibiting tumor cells proliferation | ( | |
| Onion bulb extract | HeLa cells; HCT116 cells; U2OS cells | IC50: 24.79 μg/mL for HeLa; 24.73 μg/mL for HCT116; 36.6 μg/mL for U2OS | Inducing apoptosis in cancer cells | ( | |
| Flavonol glucosides from red onion waste | HeLa cells | 5, 10, 20, 50, and 100 μM | QG, QDG, isoquercetin, and spiraeoside showed potent anticancer effect | ( | |
| Spiraeoside from red onion skin | HeLa cells | 0.1, 1, 10, 50, and 100 ug/mL | Inhibiting cell growth; promoting apoptosis by activating caspase-3 and caspase-9; inhibiting the expression of cyclin-dependent kinase 2-cyclin-E | ( | |
| Onion extract | AsPC-1, MCF-7, HCT116, HEP2, and HepG2 | Encapsulated on nano chitosan | Decreasing IC50 in cancer cell lines; inducing apoptosis by down-regulating BCL-2 level and up-regulating the activity of caspase-3 and caspase-9 | ( | |
| Onionin A from onions | LM8 cells | 4 and 20 mg/kg | Inhibiting tumor proliferation by suppressing Stat3 activation; inhibiting subcutaneous tumor development and lung metastasis | ( | |
| LM8 murine tumor-implanted model | 20 mg/kg | ||||
| Fresh yellow onion | Clinical trial | Breast cancer patients during doxorubicin-based chemotherapy | 30–40 g/d and 100–160 g/d for 8 weeks | Ameliorating hyperglycemia and insulin resistance during doxorubicin-based chemotherapy | ( |
| Onion methanol fractions and flavonols | Collagen-induced platelet aggregation in rat platelet-rich plasma | 0.5, 1, 3, and 5 mg/mL onion methanol fractions; 0.5, 1, and 2 mg/mL quercetin glycosides | Inhibiting platelet aggregation | ( | |
| Onion peel extract | High-cholesterol diet-induced male mice | 100 and 200 mg/kg/d for 12 weeks | Lowering liver weight, total cholesterol, LDL cholesterol, triacylglycerol, atherogenic index, and cardiac risk factor; increasing fecal cholesterol levels | ( | |
| Onion bulb powder | High-cholesterol diet-induced male rats | 10% onion powder in high-cholesterol diets for 7 weeks | Altering fecal bile acid composition by modulating microbiome | ( | |
| Onion bulb powder | High-cholesterol diet-induced male rats | 10% onion powder in high-cholesterol diets for 7 weeks | Modulating hepatic prostaglandins; enhancing ω-3 oxylipins in the liver; modifying sphingolipids in liver and spleen tissue | ( | |
| Onion bulb powder | High-cholesterol diet-induced male rats | 10% onion powder in high-cholesterol diets for 7 weeks | Increasing SOD, CAT, and GPx activities; anti-inflammatory response, and cardiovascular risk biomarkers | ( | |
| Onion extract | High-cholesterol diet-induced male rats | 0.5, 1.5, and 4.5 g/kg/d for 4 weeks | Alleviating hyperlipidemia with downregulation of HMGCR and upregulation of LDL receptor | ( | |
| Red wine extract of onion | Clinical trial | Healthy hypercholesterolemic volunteers | 250 mL/d (contains 10.5% of alcohol, 1.4 g/L polyphenols, and 170 mg/L total flavonoids) for 10 weeks | Altering cholesterol; improving antioxidation; inhibiting inflammatory marker levels; attenuating cardiovascular disease incidence | ( |
| Quercetin from onion skin extract powder | Clinical trial | Overweight to obese adults with hypertension | Capsule contains 132 mg onion skin extract powder, eq. 54 mg quercetin | Acute intake of quercetin does not influence post-prandial blood pressure and endothelial function | ( |
| Quercetin from onion skin extract powder | Clinical trial | Overweight to obese patients with (pre-) hypertension | 3 capsules/d (eq. 162 mg quercetin) for 6 weeks | Quercetin did not affect glucose, insulin, blood biomarkers of liver and renal function, hematology, and serum electrolytes | ( |
| Onion methanol extract | Rat dopaminergic cell line N27-A | 500 μg/mL | Upregulating antiapoptotic gene (Bcl-2); protecting against MPP+-induced death | ( | |
| Red onion ethanolic extract | Streptozotocin-induced rats | 125 and 250 mg/kg/d for 4 weeks | Improving learning and memory impairments in diabetic rats | ( | |
| Onion leave extract | Rats with neuropathic pain | 25, 50, and 100 mg/kg | Ameliorating diabetes-induced and chronic constriction injury-induced neuropathic pain | ( | |
| Onion ethanolic extract | 6-hydroxydopamine-induced rats | 50, 100, and 200 mg/kg/d | Reducing malondialdehyde levels; ameliorating cognitive dysfunction | ( | |
| Onion water extract | Pterygopalatine artery ligated mice | 300 mg/kg | Ameliorating retinal damage by regulating the expression of neurotrophic factors | ( | |
| Onion outer scale extract | Mice with cerebral ischemia-reperfusion injury | Ethyl acetate fraction: 85 and 170 mg/kg; aqueous fraction: 115 and 230 mg/kg | Improving the memory and sensorimotor functions in cerebral injury | ( | |
| Onion juice | Doxorubicin-induced rats | 1 mL for 14 days | Preventing doxorubicin -induced hepatotoxicity | ( | |
| Red onion peel extract | CCl4-induced rat hepatorenal toxicity | 50 and 100 mg/kg | Ameliorating hepatonephro-linked serum and tissue markers dose dependently | ( | |
| Onion bulb powder | High-cholesterol diet-induced rats | 10% in diets for 7 weeks | Increasing liver SOD and GPx activity; decreasing liver protein carbonyls | ( | |
| Red onion scales extract | Streptozotocin-induced rats | 150 and 300 mg/kg/d for 4 weeks | Ameliorating kidney histopathological alterations | ( | |
| Onion powder | High-fat, high sugar diet rats | 7% in diets for 7 weeks | Lowering hepatic steatosis and hepatic TNF-α gene expression | ( | |
| Quercetin-rich onion powder | Clinical trial | Healthy Japanese subjects | 9 g/d for 12 weeks | Improving liver function; lowering alanine aminotransferase level | ( |
| Onion extract | Isolated rat tracheal smooth muscle | 2, 4, 8, 16, 32, and 64 mg/ml add to organ bath every 5 min | Relaxing tracheal smooth muscle | ( | |
| Onion aqueous-alcoholic extract | Asthmatic rats sensitized with ovalbumin | 0.175, 0.35, and 0.7 mg/mL in drinking water | Decreasing tracheal responsiveness, neutrophil and eosinophil counts; increasing lymphocytes count; reducing monocyte count | ( | |
| Onion extract | Nicotine-induced lung damage in rats | 50 mg/kg/d | Attenuating the pathological effect of nicotine in the lung | ( | |
| Onion bulb extract | House dust mite-challenged male mice | 10, 30, 60, and 100 mg/kg | Mediating anti-inflammatory effects through the inhibition of the EGFR/ERK1/2/AKT-dependent pathway | ( | |
| Red onion suspension | Rats | 200 and 500 mg/kg | Mitigating various experimental triggers of gastric mucosal injury | ( | |
| Onion powder | Broiler chicks | 1.5, 2, and 2.5 g/kg in diet | Improving the population of gut microflora and intestinal histomorphology | ( | |
| Onion quercetin monoglycosides | High-fat diet fed rats | 0.15% (quercetin:quercetin monoglycosides, 98:2 and 69:31) in diet for 4 weeks | Increasing the enzymatic activity of the intestinal microbiota | ( | |
| Onion quercetin monoglycosides | Dextran sulfate sodium-induced colitis in mice | 0.15% (quercetin:quercetin monoglycosides, 98:2 and 69:31) in diet | Reducing dextran sulfate sodium-induced colitis | ( | |
| Onion bulb extract | Dextran sulfate sodium-induced colitis in mice | 30, 60, 100, and 200 mg/kg | Reducing colitis severity; regulating expression and activity of pro-inflammatory molecules and signaling pathways | ( | |
| Onion bulb extract | Isolated bone-marrow derived neutrophils | 0.01, 0.1, 1, 10, and 100 μg/ml | Reducing the percentage of viable bone-marrow derived neutrophils; increasing spontaneous apoptosis | ( | |
| Dextran sulfate sodium-induced colitis in mice | 100 and 200 mg/kg | Reducing colitis severity; regulating colonic expression/activity profile of pro-inflammatory molecules | |||
| Phenolic-rich onion extract | Broiler chicken | 1, 2, and 3 g/kg in diet | Improving growth rate by improving amino acid ileal digestibility and intestinal histology | ( | |
| Cysteine sulfoxides | Testis-derived I-10 cells | 0.3, 1, and 3 mg/mL | Enhancing progesterone production | ( | |
| Onion juice | Rats | 3 mL/d | Increasing testosterone level | ( | |
| Onion juice | Rats | 3 mL/d | Against permethrin-induced testis damages | ( | |
| Onion juice | Rats | 3 mL/d | Maintaining reproductive ability and improving sexual activities | ( | |
| Onion juice | Rats | 3 mL/d | Restoring permethrin-induced reductions in hormonal of FSH and LH levels, and gene expression of LHCGR and SF1 | ( | |
| Onion juice | Rats | 40 mg/kg/d | Improving the sperm quality and fertility after testicular torsion/detorsion | ( | |
| Onion extract | Rats | 100 and 1,000 mg/kg | Improving sperm count, motility, and morphology; ameliorating sera testosterone and SOD levels | ( | |
| Onion extract | Rats | 500 mg/kg | Protecting against dexamethasone-induced testicular damage in rats | ( | |
| Onion juice | Rats | 5 mL/kg for 21 days | Protecting against maternal dexamethasone-induced reproductive toxicity in rat female offspring | ( | |
| Onion juice | Rats | Intracavernosal injection of 200 uL | Improving dutasteride-induced erectile dysfunction in rats | ( | |
| Onion extract | Brown laying hens | 0.0032% in diet | Improving egg quality and productive performance | ( | |
| Onion bulb extract | NK CD16+ immune cells | Inducing the growth of CD16+ natural killer cells | ( | ||
| Onionin A | CD4+ and CD8+ cells | 10, 30, 50, and 100 μM | Improving the activity of lymphocytes | ( | |
| Tumor-bearing mice | 20 mg/kg/d for 2 weeks | Preventing the immunosuppressive activities of macrophages | |||
| Onion extract | Immune-suppressed rats | 500 mg/kg/d for 4 weeks | Increasing the levels of cytokines (TNF and IL-6) and immunoglobulins (IgG and IgM) | ( | |
| Onion extract | Ovalbumin-sensitized rats | 35, 70, and 140 mg/kg/d for 21 days | Decreasing the levels of IL-4 and IgE | ( | |
Figure 3The main influence factors for antioxidant activity of onion.
Figure 4The effects of onion in diabetes and diabetic complications.
The residue decline and recommend preharvest interval of commonly used pesticides in onion.
| Thiacloprid | 48 g a.i./ha (1×) | 1.92 days | 9 days | ( |
| 96 g a.i./ha (2×) | 2 days | |||
| Spinetoram | 0.031 g a.i./ha (1×) | 1.2 days | 1 day | ( |
| Spinosad | 30 g a.i./ha (1×) | 1.42 days | 0 day | |
| Propiconazole | 120 g a.i./ha (1×) | 6.1–6.2 days | ( | |
| 180 g a.i./ha (1.5×) | ||||
| Tebuconazole | 215 g a.i./ha (1×) | 1.7 days | 12 days | ( |
| 430 g a.i./ha (2×) | 2.1 days | |||
| Fluopyram plus Tebuconazole | 75 + 75 g a.i./ha (1×) | 8.8 days | 7 days | ( |
| 150 + 150 g a.i./ha (2×) | 9.1 days |
a.i./ha, active ingredient per hectare; ×, recommended dosage.